Dianthus Therapeutics | MGTA - Debt



Dianthus Therapeutics reported $1.33M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Adcock Ingram Holdings ZAR 969.4M 688.86M Dec/2024
Alaunos Therapeutics USD 0 0 Dec/2024
Avita Medical AUD 45.98M 895K Dec/2024
Celltrion KRW 2.22T 24.87B Mar/2025
Cspc Pharmaceutical CNY 507.33M 118.46M Dec/2024
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Divis Laboratories Ltd 40M 40M Mar/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Kangmei Pharma CNY 221.82M 958.68M Mar/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 2.14M 144K Dec/2024
Moderna USD 741M 4M Jun/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Organon & Co USD 8.9B 60M Jun/2025
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 1.44B 35.7M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 351.72M 15.26M Nov/2024
Viatris USD 14.76B 580.1M Jun/2025
Xeris Pharmaceuticals USD 257.22M 10.01M Jun/2025
Zz Pientze Pharmaceu 1.12B 70.31M Mar/2025